Log in
Enquire now
‌

US Patent 9365654 Anti-TrkA antibodies, derivatives and uses thereof

Patent 9365654 was granted and assigned to Rottapharm on June, 2016 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Rottapharm
Rottapharm
0
Current Assignee
Rottapharm
Rottapharm
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
93656540
Patent Inventor Names
Michela Visintin0
Gabriele Ugolini0
Gianfranco Caselli0
Lucio Claudio Rovati0
Date of Patent
June 14, 2016
0
Patent Application Number
138944890
Date Filed
May 15, 2013
0
Patent Primary Examiner
‌
Robert C Hayes
0
Patent abstract

The present invention relates to an antibody, recombinant or synthetic antigen-binding fragments thereof able to recognize and bind an epitope comprised in the TrkA amino acid sequence, medical uses thereof and a pharmaceutical composition comprising at least one of the above antibody, recombinant or synthetic antigen-binding fragments thereof.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9365654 Anti-TrkA antibodies, derivatives and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us